GS
RMD icon

GTS Securities’s ResMed RMD Stock Holding History

GTS Securities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,600
Closed -$5.76M – 3458
2024
Q3 		$5.76M Sell
23,600
-12,900
-35% -$2.88M 0.01% 801
2024
Q2 		$6.99M Sell
36,500
-7,300
-17% -$1.48M 0.01% 666
2024
Q1 		$8.67M Buy
43,800
+29,300
+202% +$5.37M 0.02% 573
2023
Q4 		$2.49M Buy
14,500
+7,400
+104% +$1.14M ﹤0.01% 1498
2023
Q3 		$1.05M Buy
+7,100
New +$1.28M ﹤0.01% 1973

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GTS Securities's RMD Position: Q1 2026 in Review

GTS Securities increased its ResMed (RMD) stake by 0.29% in Q1 2026, buying an estimated $997 and bringing the position to 1,385 shares worth $311K. The position accounts for 0.01% of the portfolio, ranked #1066.

GTS Securities first reported a position in RMD in Q4 2023 and has held it in 8 quarters since. The position peaked at $3.84M in Q4 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • GTS Securities held 1,385 shares of ResMed worth $311K as of Q1 2026.
  • GTS Securities bought 4 ResMed shares in Q1 2026, an estimated $997.
  • ResMed made up 0.01% of GTS Securities's portfolio in Q1 2026, its #1066 holding.
  • GTS Securities first reported a position in ResMed in Q4 2023 and has held it in 8 quarters since.
  • GTS Securities's ResMed position peaked at $3.84M in Q4 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.